Our Research Advisory Board comprises experts in a wide variety of research disciplines to ensure that all applications are assessed knowledgably and fairly.
As a member of the Association of Medical Research Charities we are committed to maintaining a rigorous peer review process for the assessment of research applications, for which the Advisory Board are responsible. This process ensures that only the highest quality research at the best institutions receives DRWF funding. When we are awarding a DRWF Fellowship, we are also intent on rewarding determined and committed individuals who have a proven track record in diabetes research and can display an intention to continue working in the field. It is our hope that a DRWF Fellowship can serve as a significant and fruitful step in the career of a bright, young and ambitious researcher.
Our current Board members are:
Chairman - Professor David R Matthews, MA, DPhil, BM, BCh, FRCP
Harris Manchester College – University of Oxford
Oxford Centre for Diabetes Endocrinology & Metabolism
David Matthews is currently Professor of Diabetes Medicine, University of Oxford, and is Medical Tutor and Vice Principal at Harris Manchester College, Oxford (www.hmc.ox.ac.uk). He is the emeritus founding chairman of the Oxford Centre for Diabetes, Endocrinology and Metabolism.
His academic research interests include mathematical modelling of insulin resistance, homeostatic model assessment of beta-cell function and insulin resistance. He is the author of the HOMA model. He has a long-standing interest in the new therapeutic agents for type 2 diabetes. An emerging and vital concern has been the global obesity epidemic – and the pandemic of diabetes. He was a co-investigator of the UKPDS. He was a founding trustee of the Oxford Health Alliance (www.oxha.org) – campaigning and researching on chronic disease. He was the first Executive Director of the Global Alliance for Chronic Disease; a world-wide association of six research councils collaborating in the fight against Chronic Disease. He is Co-Director of the UK Diabetes Research Network. He has authored more than 230 publications and is on the editorial boards of several professional journals.
His interest in epidemic chronic disease stems from the concern that we are facing a pandemic of diabetes found in both developing and developed countries. The web site www.oxha.org gives more details of this. The Banting Lecture at Diabetes UK in 2010 was given in recognition of this work. He has set up a web site of diabetes experiences which is www.diabetes-stories.com.
He was educated at Corpus Christi College, Oxford, where he was made Senior Scholar. He was an MRC scholar while studying for his DPhil and subsequently a Junior Research Fellow at Balliol College and the Joan and Richard Doll Senior Research Fellow at Green College.
Professor Paul Squires
Professor in Biomedical Science (Diabetes & Endocrinology) Paul Squires is Professor of Biomedical Science at the Joseph Banks Laboratories, University of Lincoln (2014-present). He was previously a Reader in Diabetes & Endocrinology and Course Director for Biomedical Science at the University of Warwick and a Diabetes UK, RD Lawrence Research Fellow (King’s College London).
With 25yrs experience researching diabetes, including placements at the University of British Columbia in Canada and Uppsala University, Sweden, he has published 70+ papers and contributed to Research Advisory Boards for Diabetes UK, the European Foundation for the Study of Diabetes and DRWF. Prof. Squires studies sub-cellular mechanisms that regulate insulin secretion and action and his Group is currently involved in determining how cell-cell adhesion, cell-coupling and cell-to-cell communication synchronize activity and function within the renal nephron and pancreatic islet.
Dr. Ian Salt PhD
Ian graduated as a biochemist at the University of Bristol prior to gaining his Ph.D. in beta-cell biochemistry from the University of Dundee in 1997. He held fellowships from the British Heart Foundation and Diabetes UK before taking up his current academic post at the University of Glasgow. Ian is currently a senior lecturer in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow. His principal research interests are the molecular mechanisms that link diabetes, insulin resistance and the risk of developing cardiovascular disease.
Professor Anna Gloyn DPhil
Anna Gloyn is currently a Wellcome Trust Senior Fellow in Basic and Biomedical Science based at the Oxford Centre for Diabetes Endocrinology and Metabolism at the University of Oxford. Anna completed her DPhil at the University of Oxford under the supervision of Professor Robert Turner. Her post-doctoral training was carried out at the Peninsula Medical School under the mentorship of Professors Andrew Hattersley & Sian Ellard and at the University of Pennsylvania in Philadelphia under the mentorship of Professor Franz Matschinsky.
Anna’s research is focused on using naturally occurring mutations in humans as tools to identity critical regulatory pathways and insights into normal physiology. Anna’s early post-doctoral research led to the identification a new genetic aetiology for permanent and transient neonatal diabetes due to KCNJ11 mutations and resulted in one of the first examples of the determination of the molecular genetic aetiology leading to improved treatment options for patients (Gloyn et al New England Journal of Medicine 2004). Recently the Gloyn group have reported a novel genetic cause of constitutive insulin sensitivity in humans due to mutations in the PTEN gene (Pal et al New England Journal of Medicine 2012).
Current research projects are focused on the translation of association signals for type 2 diabetes and glycaemic traits into molecular, cellular and physiological mechanisms and clinically useful tools. Anna is an active member of several international consortia, including DIAGRAM (Diabetes Genetics Replication and Meta-analysis), MAGIC (Meta-analysis of Glucose and Insulin traits Consortium) and the Genetics of Type 2 Diabetes (GoT2D).
Anna’s work has been recognized both nationally and internationally as she is a recipient of a Diabetes UK RD Lawrence research fellowship (2003), a European Association for the Study of Diabetes Rising Star Award (2005), a Medical Research Council New Investigator Award (2007), the RD Lawrence Named Lecturer (Diabetes UK Annual Professional Conference 2009) and most recently a Wellcome Trust Senior Fellowship in Basic Biomedical Research (2011).
Professor Rory McCrimmon
Dr Rory McCrimmon underwent his basic medical training at the University of Edinburgh and completed his clinical training in the South-East of Scotland before becoming an NHS Consultant Physician in Diabetes and Endocrinology at University Hospital Aintree, Liverpool, in 2000. In 2002, he left his NHS position and joined the faculty at Yale University, Connecticut, to further develop his basic research in the central regulation of glucose homeostasis. In 2009 he returned to the UK to join the University of Dundee and is currently a Clinical Reader in Translational Medicine.
Dr Luigi Gnudi MD PhD FRCP FASN
Professor of Diabetes & Metabolic Medicine, King’s College London School of Medicine, Cardiovascular Division, Waterloo Campus, London, UK
Luigi Gnudi obtained his MD with Honours from the University of Parma (Italy) in 1988. He subsequently joined the residency programme in Diabetes and Endocrinology at the University of Padua Medical School - Italy (1989-1993). During 1992-1995 he worked as a postdoctoral fellow with Prof Barbara B Kahn at Beth Israel Hospital, Harvard Medical School in Boston. In 1999 he obtained a PhD in Endocrinological Sciences from the University of Milan and in 2005 he became a Fellow of both the Royal College of Physicians and the American Society of Nephrology.
In 1997 Luigi Gnudi was appointed Senior Lecturer in the Unit for Metabolic Medicine within the Cardiovascular Division of King’s College London School of Medicine, and in 2011, was promoted to Professor of Diabetes & Metabolic Medicine. He has been Head of the Unit for Metabolic Medicine since 2010. He is an Honorary Consultant Physician in Diabetes, Endocrinology and Metabolic Medicine at Guy's and St. Thomas' Hospital NHS Foundation Trust in London.
Luigi Gnudi is subject editor for Nephrology Dialysis and Transplantation, and Metabolism. He is a member of Diabetes UK, European Association for the Study of Diabetes, American Diabetes Association, American Society of Nephrology, European Diabetic Nephropathy Study Group, Physiological Society, ERA-EDTA, and Faculty 1000.
He speaks frequently at national and international meetings and is an active researcher, clinician, and teacher with major research interests in the study of diabetic nephropathy and diabetic vascular complications in man. He has published more than 70 original papers, books and monographs and meeting proceedings on these topics.
Professor Angela Shore, Vice-Dean Research, University of Exeter Medical School
Professor Angela Shore is the inaugural Vice-Dean Research for the University of Exeter Medical School, and was previously Interim Vice-Dean Research for the Peninsula College of Medicine and Dentistry since 2009. She is the Scientific Director of the NIHR Exeter Clinical Research Facility for Experimental Medicine and Associate Director for Experimental Medicine for the UKCRN diabetes research network.
Professor Shore graduated in Physiology from the University of Newcastle and was awarded her PhD for an investigation of the vascular mechanisms underlying fluid homeostasis in patients with Liver Disease. Following postdoctoral positions at the University of London where she expanded her research into the vascular aspects of hypertension, Professor Shore moved to the Postgraduate Medical School Exeter in 1987 to establish the clinical microvascular research unit funded by the Wellcome Trust. Currently Professor Shore’s work which is funded by the British Heart Foundation, Diabetes UK, European Union IMI JU and NIHR investigates novel approaches to the identification of early vascular complications and patient stratification for cardiovascular risk.
She was appointed Professor of Cardiovascular Science in 2000. As the Interim Vice Dean for Research and previously the Director for the Institute of Biomedical and Clinical Science, Professor Shore played a central role in the research success of the Peninsula College of Medicine and Dentistry, driving the research strategy, the appointment of new staff and the development of state of the art facilities. She also led the last three successful RAE submissions. Professor Shore is committed to interdisciplinary research and was instrumental in the establishment of the University of Exeter Science Strategy Theme “Translational Medicine, Personalised Medicine and Public Health” to drive forward this approach. Professor Shore is actively involved in Microcirculation research worldwide. She is Treasurer of the European Society for Microcirculation, and represents Europe on the International Liaison Committee.
Professor Peter Jones, King’s College London
Peter Jones is Professor of Endocrine Biology in the Diabetes Research Group at the Guy’s campus of King’s College London. Peter obtained his PhD at the National Institute for Medical Research (London) studying peptide hormones in the central nervous system. He started working on β-cell function in diabetes as a postdoctoral fellow at Queen Elizabeth College in 1984. He was awarded an R.D. Lawrence Fellowship by the British Diabetic Association, followed by a Medical Research Council Senior Research Fellowship, after which he took up an academic position as Lecturer in Physiology at King’s. He was awarded the British Diabetic Association R.D. Lawrence Lecture for 1997 and the Diabetes UK Dorothy Hodgkin Lecture for 2015 in recognition of his work on β-cell function. His research interests remain with the β-cell, with current focus on cell-cell interactions within islets of Langerhans, strategies for improving islet transplantation therapy for Type 1 diabetes and novel therapeutic targets for Type 2 diabetes.
Professor Kath Barnard PhD CPsychol AFBPsS
Health Psychologist / Visiting Professor, Bournemouth University
Professor Katharine Barnard, Chartered Health Psychologist, specializes in the psychosocial impact and management of diabetes. She has a longstanding research interest in the psychosocial issues associated with diabetes and its management. Through this research, a greater understanding has been gained of the factors that contribute to therapy choices and quality of life; and the impact that diabetes and its’ treatment has on both the individuals with the condition and their family members.The effect of diabetes, both medically and psychologically in terms of everyday coping, psychosocial impact, functional health status and psychological burden, is a multifaceted and complex area and Professor Barnard’s research to date has made significant advances in unravelling some of these complexities. Professor Barnard has published extensively, is often invited to speak both nationally and internationally and leads cutting edge postgraduate training.
Professor Barnard’s currently leading on psychosocial aspects within several multi-centre RCTs evaluating diabetes technologies such as closed-loop, insulin pump therapy and bolus calculators. She is the PI of the INSPIRE study into psych aspects of artificial pancreas devices; the UK psychological lead on global diabetes attitudes wishes and needs research; Principal Investigator in a programme of research to minimise alcohol associated risks for young adults with T1DM; is engaged in ongoing research in co-morbid depression and diabetes; health technology assessment; and patient-professional communication to support enhanced self-management and motivation. Professor Barnard is a recent Chair of the Diabetes UK Annual Professional Conference, Expert Advisor to NICE, Associate Lecturer at a number of UK universities and sits on the editorial boards of several journals and funding bodies.